VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) —
Agra Ventures Ltd.
(“AGRA”
or
the
“Company”)
(CSE: AGRA)
(OTC:
AGFAF) (FRA:
PU30),
a growth-oriented and diversified company focused on the international cannabis industry, applauds Health Canada’s recently announced regulatory changes that will have the effect of streamlining the application process for cannabis processors to bring products to market more quickly. On March 31, 2022, Health Canada communicated that it would begin granting all standard and micro-class processing license holders sales authorizations for dried and fresh cannabis products during the initial licensing process. Therefore, licensees such as AGRA will no longer have to apply for an amendment in order to sell to wholesalers. The planned improvements to the licensing process are scheduled to go into effect on April 19, 2022.
Existing licences that do not currently authorize the sale of dried and fresh cannabis products will be reissued with amended conditions within the next 90 days. Once a holder’s licence has been amended, and 60 days have passed after submitting a Notification of New Cannabis Product for any dried or fresh cannabis product, the holder will be able to sell those products into provincial markets, pending local approval. However, an amendment will still be required in order to sell cannabis extracts, cannabis topicals and edible cannabis products. The changes are part of the federal regulator’s ongoing efforts to improve Canada’s cannabis program based on consultations with and feedback from the industry.
Management Commentary
“The regulatory changes recently announced by Health Canada are a welcome improvement of the licensing process for AGRA and the entire Canadian cannabis industry. Although we remain focused on our business-to-business strategy of growing great cannabis and selling it in dried form to other licensed producers in Canada, the changes give us optionality that we didn’t have before, which I believe adds value to our organization,” said Elise Coppens, CEO of AGRA. “Our team commends Health Canada on its open-mindedness, applauds the outcome of its process and endorses the changes that have emerged and are planned to be in effect shortly,” added Ms. Coppens.
Additional Debenture Amendment
In addition to the recently announced agreement with holders of the Company’s 10.00% Senior Unsecured Convertible Debentures (the “
Debentures
”) to amend the Debentures to extend the maturity date for an additional twelve months to March 12, 2023, the Company has further agreed to amend the applicable conversion price of the Debentures to a price per share equal to the volume weighted average trading price of the Company’s common shares on the CSE for the five trading days prior to the applicable conversion date, subject to a minimum issue price of $0.05.
About
Agra Ventures Ltd.
Agra Ventures is a growth-oriented and diversified company focused on the international cannabis industry. The company is dedicated to the cultivation, distribution and marketing of high-quality cannabis and cannabis-infused products worldwide. Agra Ventures’ primary asset in Canada is Boundary Bay Cannabis located in Delta, BC, which is one of the largest cannabis greenhouse facilities focused on the cost-optimized cultivation of high-potency cannabis. Abroad, the company’s wholly owned subsidiary, Farmako GmbH, is focused on becoming Europe’s leading distributor of medical cannabis. Farmako currently has active product distribution operations in Germany and is fully licensed in the United Kingdom.
For more information about Agra Ventures, please visit
www.agraventures.com
and its profile page on SEDAR at
www.sedar.com
.
ON
BEHALF
OF
THE
BOARD
OF
DIRECTORS
Nick Kuzyk, Investor Relations
E:
[email protected]
T: (800) 783-6056
The
CSE
and
Information
Service
Provider
have
not
reviewed
and
does
not
accept
responsibility
for
the
accuracy
or
adequacy
of
this
release.
Forward-looking
Information
Cautionary
Statement
Except
for
statements
of
historic
fact
this
news
release
contains
certain
“forward-looking
information” within the meaning of applicable securities law. Forward-looking information is
frequently
characterized
by
words
such
as
“plan”
“expect”
“project”
“intend”
“believe”
“anticipate” “estimate” and other similar words or statements that certain events or conditions
“may” or “will” occur. Forward-looking statements are based on the opinions and estimates at
the date the statements are made and are subject to a variety of risks and uncertainties and other
factors that could cause actual events or results to differ materially from those anticipated in the
forward-looking statements including but not limited to delays or uncertainties with regulatory
approvals
including
that
of
the
CSE.
There
are
uncertainties
inherent
in
forward-looking
information including factors beyond the Company’s control. There are no assurances that the
business
plans
for
Agra Ventures described
in
this
news
release
will
come
into
effect
on
the terms or time frame described herein. The Company undertakes no obligation to update
forward-looking information if circumstances or management’s estimates or opinions should
change except as required by law. The reader is cautioned not to place undue reliance on
forward-looking statements. Additional information identifying risks and uncertainties that could
affect financial results is contained in the Company’s filings with Canadian securities regulators
which
are
available
at
www.sedar.com.
SOURCE: Agra Ventures Ltd.
